AU Patent

AU2003294262B2 — Methods of administering dalbavancin for treatment of bacterial infections

Assigned to Vicuron Pharmaceuticals LLC · Expires 2007-08-23 · 19y expired

What this patent protects

Patent listed against dalbavancin-hydrochloride.

Drugs covered by this patent

dalbavancin-hydrochloride (DALBAVANCIN HYDROCHLORIDE)

Patent Metadata

Patent number: AU2003294262B2
Jurisdiction: AU
Classification: —
Expires: 2007-08-23
Drug substance claim: No
Drug product claim: No
Assignee: Vicuron Pharmaceuticals LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.